201 related articles for article (PubMed ID: 31790558)
1. VISTA Is Crucial for Corneal Allograft Survival and Maintenance of Immune Privilege.
Kunishige T; Taniguchi H; Ohno T; Azuma M; Hori J
Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):4958-4965. PubMed ID: 31790558
[TBL] [Abstract][Full Text] [Related]
2. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege.
Kunishige T; Taniguchi H; Terada M; Akiba H; Yagita H; Abe R; Hori J
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6815-6823. PubMed ID: 28002569
[TBL] [Abstract][Full Text] [Related]
3. Two different regulatory T cell populations that promote corneal allograft survival.
Cunnusamy K; Paunicka K; Reyes N; Yang W; Chen PW; Niederkorn JY
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6566-74. PubMed ID: 20702818
[TBL] [Abstract][Full Text] [Related]
4. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.
Niederkorn JY; Mayhew E; Mellon J; Hegde S
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection.
Chen X; Zhao S; Tang X; Ge H; Liu P
Mol Vis; 2011; 17():2148-56. PubMed ID: 21850190
[TBL] [Abstract][Full Text] [Related]
6. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
Yamada J; Kurimoto I; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice.
Asai T; Choi BK; Kwon PM; Kim WY; Kim JD; Vinay DS; Gebhardt BM; Kwon BS
Immunology; 2007 Jul; 121(3):349-58. PubMed ID: 17376197
[TBL] [Abstract][Full Text] [Related]
8. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression.
Beutelspacher SC; Pillai R; Watson MP; Tan PH; Tsang J; McClure MO; George AJ; Larkin DF
Eur J Immunol; 2006 Mar; 36(3):690-700. PubMed ID: 16482510
[TBL] [Abstract][Full Text] [Related]
9. Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.
Shimmura-Tomita M; Wang M; Taniguchi H; Akiba H; Yagita H; Hori J
PLoS One; 2013; 8(5):e63620. PubMed ID: 23667648
[TBL] [Abstract][Full Text] [Related]
10. Corneal Nerve Ablation Abolishes Ocular Immune Privilege by Downregulating CD103 on T Regulatory Cells.
Neelam S; Niederkorn JY
Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):25. PubMed ID: 32305043
[TBL] [Abstract][Full Text] [Related]
11. CD95 ligand expression on corneal epithelium and endothelium influences the fates of orthotopic and heterotopic corneal allografts in mice.
Osawa H; Maruyama K; Streilein JW
Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1908-15. PubMed ID: 15161857
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells.
Sonoda KH; Taniguchi M; Stein-Streilein J
J Immunol; 2002 Feb; 168(4):2028-34. PubMed ID: 11823540
[TBL] [Abstract][Full Text] [Related]
13. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule.
Hori J; Joyce N; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):443-52. PubMed ID: 10670474
[TBL] [Abstract][Full Text] [Related]
14. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
[TBL] [Abstract][Full Text] [Related]
15. Latanoprost does not affect immune privilege of corneal allografts.
Wang M; Kitahara Y; Yoshida A; Hori J
Exp Eye Res; 2008 Feb; 86(2):394-402. PubMed ID: 18187130
[TBL] [Abstract][Full Text] [Related]
16. Anterior chamber-associated immune deviation promotes corneal allograft survival.
Niederkorn JY; Mellon J
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic Sensitization and Tolerance Induction After Corneal Endothelial Cell Transplantation in Mice.
Yamada J; Ueno M; Toda M; Shinomiya K; Sotozono C; Kinoshita S; Hamuro J
Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4572-80. PubMed ID: 27603721
[TBL] [Abstract][Full Text] [Related]
18. Blockade of costimulatory CD27/CD70 pathway promotes corneal allograft survival.
Narimatsu A; Hattori T; Usui Y; Ueno H; Funaki T; Komatsu H; Nakagawa H; Akiba H; Goto H
Exp Eye Res; 2020 Oct; 199():108190. PubMed ID: 32798537
[TBL] [Abstract][Full Text] [Related]
19. Immune privilege and immunogenicity reside among different layers of the mouse cornea.
Hori J; Joyce NC; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3032-42. PubMed ID: 10967061
[TBL] [Abstract][Full Text] [Related]
20. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival.
Skelsey ME; Mellon J; Niederkorn JY
J Immunol; 2001 Apr; 166(7):4327-33. PubMed ID: 11254685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
